Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
Insulin is a chemical that the body needs in order to use or store sugar. It is made by a
type of cell called a beta cell which resides in an organ known as the pancreas. Type 2
diabetes is a disease where the beta cells are unable to meet a person's insulin needs. Sugar
levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new
beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic
patients.